NZSE - Delayed Quote NZD

Comvita Limited (CVT.NZ)

Compare
0.9900 0.0000 (0.00%)
At close: November 29 at 3:19 PM GMT+13
Loading Chart for CVT.NZ
DELL
  • Previous Close 0.9900
  • Open 1.0000
  • Bid 0.9800 x 351000
  • Ask 0.9900 x 350000
  • Day's Range 0.9900 - 1.0000
  • 52 Week Range 0.9500 - 2.6600
  • Volume 5,513
  • Avg. Volume 29,781
  • Market Cap (intraday) 69.776M
  • Beta (5Y Monthly) 0.33
  • PE Ratio (TTM) --
  • EPS (TTM) -1.1000
  • Earnings Date Feb 19, 2025 - Feb 25, 2025
  • Forward Dividend & Yield 0.04 (4.04%)
  • Ex-Dividend Date Apr 3, 2024
  • 1y Target Est 1.22

Comvita Limited, together with its subsidiaries, engages in research, manufacturing, marketing, and distribution nature health products in Australia, New Zealand, Greater China, rest of Asia, North America, Europe, the Middle East, Africa, and internationally. The company offers Manuka honey, propolis, olive leaf extract, medihoney, bundles, bulk packs, and elixirs and lozenges, as well as oral care and kids health products. It also provides solutions for digestive health, skin health, heart and metabolic health, and immunity. In addition, the company engages in the apiary ownership and forest management. It offers its products through supermarkets, department stores, and health stores, as well as online. Comvita Limited was incorporated in 1974 and is based in Te Puke, New Zealand.

www.comvita.co.nz

550

Full Time Employees

June 30

Fiscal Year Ends

Recent News: CVT.NZ

View More

Performance Overview: CVT.NZ

Trailing total returns as of 11/29/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

CVT.NZ
56.75%
S&P/NZX 50 INDEX GROSS ( GROSS
11.01%

1-Year Return

CVT.NZ
60.53%
S&P/NZX 50 INDEX GROSS ( GROSS
16.69%

3-Year Return

CVT.NZ
70.50%
S&P/NZX 50 INDEX GROSS ( GROSS
3.48%

5-Year Return

CVT.NZ
61.68%
S&P/NZX 50 INDEX GROSS ( GROSS
15.47%

Compare To: CVT.NZ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: CVT.NZ

View More

Valuation Measures

Annual
As of 9/2/2024
  • Market Cap

    139.55M

  • Enterprise Value

    240.82M

  • Trailing P/E

    22.16

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.34

  • Price/Book (mrq)

    0.43

  • Enterprise Value/Revenue

    1.18

  • Enterprise Value/EBITDA

    10.93

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -37.87%

  • Return on Assets (ttm)

    -2.12%

  • Return on Equity (ttm)

    -38.70%

  • Revenue (ttm)

    204.34M

  • Net Income Avi to Common (ttm)

    -77.39M

  • Diluted EPS (ttm)

    -1.1000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    8.16M

  • Total Debt/Equity (mrq)

    68.12%

  • Levered Free Cash Flow (ttm)

    -80.38k

Research Analysis: CVT.NZ

View More

Company Insights: CVT.NZ

Research Reports: CVT.NZ

View More

People Also Watch